Protection against influenza virus challenge by topical application of influenza DNA vaccine

被引:66
作者
Watabe, S
Xin, KQ
Ihata, A
Liu, LJ
Honsho, A
Aoki, I
Hamajima, K
Wahren, B
Okuda, K
机构
[1] Yokohama City Univ, Sch Med, Dept Bacteriol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan
[2] Yokohama City Univ, Sch Med, Dept Internal Med, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan
[3] Yokohama City Univ, Sch Med, Dept Pathol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan
[4] Karolinska Inst, Microbiol & Tumorbiol Ctr, Swedish Inst Infect Dis Control, Stockholm, Sweden
关键词
topical application; DNA vaccine; influenza virus;
D O I
10.1016/S0264-410X(01)00194-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We studied the use of a DNA vaccine expressing the matrix (M) gene of the influenza virus A/PR/8/34. Mice were immunized by painting the DNA vaccine three times on the skin after removal of its keratinocytic layers. Immunization by this method produced M-specific antibodies and cytotoxic T lymphocyte (CTL) response, and acquired resistance against influenza virus challenge. This protection was abrogated by the in vivo injection of anti-CDS or anti-CD4 monoclonal antibody. We further found that simultaneous topical application (t.a.) of GM-CSF expression plasmid (pGM-CSF) or liposomes plus mannan produced stronger immune response competence and enhanced the protective effect against influenza virus challenge. The present study revealed that administering DNA vaccine by topical application can elicit both humoral and cell-mediated immunity (CMI). (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:4434 / 4444
页数:11
相关论文
共 44 条
[1]   ANTIGENIC STRUCTURE OF MYOGLOBIN - COMPLETE IMMUNOCHEMICAL ANATOMY OF A PROTEIN AND CONCLUSIONS RELATING TO ANTIGENIC STRUCTURES OF PROTEINS [J].
ATASSI, MZ .
IMMUNOCHEMISTRY, 1975, 12 (05) :423-438
[2]   PROTECTION AGAINST MYCOPLASMA-INFECTION USING EXPRESSION-LIBRARY IMMUNIZATION [J].
BARRY, MA ;
LAI, WC ;
JOHNSTON, SA .
NATURE, 1995, 377 (6550) :632-635
[3]   Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination [J].
Boyer, JD ;
Ugen, KE ;
Wang, B ;
Agadjanyan, M ;
Gilbert, L ;
Bagarazzi, ML ;
Chattergoon, M ;
Frost, P ;
Javadian, A ;
Williams, WV ;
Refaeli, Y ;
Ciccarelli, RB ;
McCallus, D ;
Coney, L ;
Weiner, DB .
NATURE MEDICINE, 1997, 3 (05) :526-532
[4]   NEUTRALIZATION OF HIV-1 BY SECRETORY IGA INDUCED BY ORAL IMMUNIZATION WITH A NEW MACROMOLECULAR MULTICOMPONENT PEPTIDE VACCINE CANDIDATE [J].
BUKAWA, H ;
SEKIGAWA, KI ;
HAMAJIMA, K ;
FUKUSHIMA, J ;
YAMADA, Y ;
KIYONO, H ;
OKUDA, K .
NATURE MEDICINE, 1995, 1 (07) :681-685
[5]   Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope [J].
Casares, S ;
Inaba, K ;
Brumeanu, TD ;
Steinman, RM ;
Bona, CA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (09) :1481-1486
[6]   Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs [J].
Chen, Z ;
Matsuo, K ;
Asanuma, H ;
Takahashi, H ;
Iwasaki, T ;
Suzuki, Y ;
Aizawa, C ;
Kurata, T ;
Tamura, S .
VACCINE, 1999, 17 (7-8) :653-659
[7]  
CLERICI M, 1991, J IMMUNOL, V146, P2214
[8]   DNA-BASED IMMUNIZATION INDUCES CONTINUOUS SECRETION OF HEPATITIS-B SURFACE-ANTIGEN AND HIGH-LEVELS OF CIRCULATING ANTIBODY [J].
DAVIS, HL ;
MICHEL, ML ;
WHALEN, RG .
HUMAN MOLECULAR GENETICS, 1993, 2 (11) :1847-1851
[9]   Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine [J].
Deck, RR ;
DeWitt, CM ;
Donnelly, JJ ;
Liu, MA ;
Ulmer, JB .
VACCINE, 1997, 15 (01) :71-78
[10]   PRECLINICAL EFFICACY OF A PROTOTYPE DNA VACCINE - ENHANCED PROTECTION AGAINST ANTIGENIC DRIFT IN INFLUENZA-VIRUS [J].
DONNELLY, JJ ;
FRIEDMAN, A ;
MARTINEZ, D ;
MONTGOMERY, DL ;
SHIVER, JW ;
MOTZEL, SL ;
ULMER, JB ;
LIU, MA .
NATURE MEDICINE, 1995, 1 (06) :583-587